Chargement en cours...

Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis

BACKGROUND: For patients with MS, medication switches increase the risk of disease reactivation. OBJECTIVE: Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. METHODS:...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mult Scler J Exp Transl Clin
Auteurs principaux: Norborg, Hilde, Riise, Trond, Myhr, Kjell-Morten, Grytten, Nina, Wergeland, Stig
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8209840/
https://ncbi.nlm.nih.gov/pubmed/34188949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20552173211022027
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!